J. Lee, T. Mok, P. Garrido, E. Kim, C. Arslan, M. Tsuboi, T. Dong, C. Blin, V. Rodrik-Outmezguine, B. Mookerjee, V. Passos, J. Pujol
{"title":"Canakinumab或Pembrolizumab作为手术切除的非小细胞肺癌患者的单药或联合新辅助治疗:CANOPY-N试验","authors":"J. Lee, T. Mok, P. Garrido, E. Kim, C. Arslan, M. Tsuboi, T. Dong, C. Blin, V. Rodrik-Outmezguine, B. Mookerjee, V. Passos, J. Pujol","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4803","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":369815,"journal":{"name":"TP137. TP137 THORACIC ONCOLOGY: DIAGNOSIS AND TREATMENT: IP, SURGERY, AND RADIATION","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Patients with Surgically Resected Non-Small Cell Lung Cancer: CANOPY-N Trial\",\"authors\":\"J. Lee, T. Mok, P. Garrido, E. Kim, C. Arslan, M. Tsuboi, T. Dong, C. Blin, V. Rodrik-Outmezguine, B. Mookerjee, V. Passos, J. Pujol\",\"doi\":\"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4803\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":369815,\"journal\":{\"name\":\"TP137. TP137 THORACIC ONCOLOGY: DIAGNOSIS AND TREATMENT: IP, SURGERY, AND RADIATION\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"TP137. TP137 THORACIC ONCOLOGY: DIAGNOSIS AND TREATMENT: IP, SURGERY, AND RADIATION\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4803\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP137. TP137 THORACIC ONCOLOGY: DIAGNOSIS AND TREATMENT: IP, SURGERY, AND RADIATION","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4803","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Patients with Surgically Resected Non-Small Cell Lung Cancer: CANOPY-N Trial